Pharsight

Drugs that contain Alvimopan

1. Entereg patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946262 CUBIST PHARMS Methods of preventing and treating gastrointestinal dysfunction
Feb, 2030

(5 years from now)

Market Authorisation Date: 20 May, 2008

Treatment: A method to accelerate the time to gastrointestinal recovery by administering about 12 mg of alvimopan to the patient from about 30 to 60 minutes prior to surgery

Dosage: CAPSULE;ORAL

How can I launch a generic of ENTEREG before it's drug patent expiration?
More Information on Dosage

ENTEREG family patents

Family Patents